ELTP (Elite Pharmaceuticals) Shiller PE Ratio: (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ELTP Elite Pharmaceuticals Inc ELTP
60 GF Score
Price $0.26
GF Value $0.52
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Elite Pharmaceuticals Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Elite Pharmaceuticals  (OTCPK:ELTP) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Elite Pharmaceuticals Shiller PE Ratio Related Terms


Elite Pharmaceuticals Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Elite Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elite Pharmaceuticals Shiller PE Ratio Chart

Elite Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1,078.12

Elite Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 83.02 1,078.12 207.33

ELTP vs EBS, ANIK, AKBA: Shiller PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Elite Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elite Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elite Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Elite Pharmaceuticals's Shiller PE Ratio falls into.


ELTP
60GF Score
Elite Pharmaceuticals Inc ELTP
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elite Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Elite Pharmaceuticals's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Elite Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.01/333.9520*333.9520
=0.010

Current CPI (Jun. 2026) = 333.9520.

Elite Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -0.002 241.428 -0.003
201612 0.000 241.432 0.000
201703 -0.007 243.801 -0.010
201706 -0.003 244.955 -0.004
201709 0.002 246.819 0.003
201712 -0.001 246.524 -0.001
201803 -0.004 249.554 -0.005
201806 -0.002 251.989 -0.003
201809 -0.003 252.439 -0.004
201812 -0.003 251.233 -0.004
201903 0.000 254.202 0.000
201906 0.000 256.143 0.000
201909 -0.002 256.759 -0.003
201912 -0.002 256.974 -0.003
202003 0.001 258.115 0.001
202006 0.001 257.797 0.001
202009 0.001 260.280 0.001
202012 0.002 260.474 0.003
202103 -0.006 264.877 -0.008
202106 0.002 271.696 0.002
202109 0.001 274.310 0.001
202112 0.002 278.802 0.002
202203 0.000 287.504 0.000
202206 0.000 296.311 0.000
202209 0.001 296.808 0.001
202212 0.003 296.797 0.003
202303 -0.001 301.836 -0.001
202306 0.001 305.109 0.001
202309 0.010 307.789 0.011
202312 0.000 306.746 0.000
202403 0.000 312.332 0.000
202406 0.000 314.175 0.000
202409 -0.010 315.301 -0.011
202412 -0.010 315.605 -0.011
202503 0.020 319.799 0.021
202506 -0.010 322.561 -0.010
202509 0.010 324.800 0.010
202512 0.010 324.054 0.010
202603 0.010 330.213 0.010
202606 0.010 333.952 0.010

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Elite Pharmaceuticals (ELTP) Overvalued in 2026?

Based on GuruFocus' analysis, Elite Pharmaceuticals stock appears to be undervalued. The current stock price of $0.26 is trading 50.4% below its estimated GF Value™ of $0.52. GuruFocus considers Elite Pharmaceuticals to be Significantly Undervalued.

Key valuation signals for ELTP:

  • Shiller PE Ratio:
  • GF Value™: $0.52 vs. price of $0.26 (50.4% below fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the ELTP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Elite Pharmaceuticals Business Description

Address 165 Ludlow Avenue, Northvale, NJ, USA, 07647
Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; developing additional generic pharmaceutical products; development of other products in its pipeline including the products with its partners; and commercialization of new products.
60GF Score

Get the complete analysis for ELTP

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price
$0.52
GF Value